ランキング
価格
はじめての方へ
ログイン
無料体験
米国企業
Reneo Pharmaceuticals, Inc.
Reneo Pharmaceuticals, Inc.
RPHM
時価総額
$6062.7万
PER
マイリストに追加
マイリストに追加
サマリーテーブルに戻る
十億
百万
千
USD
年次
四半期
Download CSV
損益計算書
バランスシート
キャッシュフロー
2021年
12月31日
2022年
12月31日
Net loss
-40
-52
Stock-based compensation
4
4
Depreciation and amortization
0
0
Amortization/accretion on short-term investments
-0
1
Changes in the fair value of performance award
0
-0
Non-cash lease expense
-
-0
Loss on disposal of fixed asset
-
-0
Prepaid expenses and other assets
5
-1
Accounts payable and accrued expenses
2
1
Operating lease liabilities
-
-0
Net cash used in operating activities
-38
-47
Purchase of property and equipment
0
0
Purchase of available-for-sale short-term investments
31
102
Proceeds from maturities of available-for-sale short-term investments
8
44
Net cash used in investing activities
-23
-58
Proceeds from Issuance of Convertible Preferred Stock
47
-
Proceeds from Issuance of Common Stock
85
0
Proceeds from issuance of common stock in connection with equity plans
-
0
Net cash provided by financing activities
132
0
Net (decrease) increase in cash and cash equivalents
71
-105
Right-of-use assets obtained in exchange for lease obligations
-
2
Vesting of unvested exercised options
0
-